| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
26,020,000 |
| Market
Cap: |
245.11(M) |
| Last
Volume: |
6,675 |
Avg
Vol: |
6,656 |
| 52
Week Range: |
$6.48 - $11.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Home Health Care |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Fennec Pharmaceuticals is a biopharmaceutical company focused on the development of PEDMARK™ (sodium thiosulfate anhydrous injection) for the prevention of platinum-induced ototoxicity in pediatric cancer patients. Co. has licensed from Oregon Health & Science University intellectual property rights for the use of PEDMARK™ as a chemoprotectant and is developing PEDMARK™ as a protectant against the hearing loss caused by platinum-based anti-cancer agents in children.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
41,667 |
41,667 |
41,667 |
41,667 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
2 |
2 |
2 |
2 |
| Total Shares Sold |
384,683 |
445,042 |
481,476 |
532,549 |
| Total Sell Value |
$3,266,840 |
$3,836,454 |
$4,152,217 |
$4,642,390 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
18 |
24 |
31 |
38 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Frank Morgan C. |
10% Owner |
– – • |
2017-03-30 |
4 |
B |
$2.80 |
$1,960 |
I/I |
700 |
2,171,482 |
1.42 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-03-27 |
4 |
B |
$2.68 |
$5,360 |
D/D |
2,000 |
1,644,899 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-03-27 |
4 |
B |
$2.68 |
$5,360 |
I/I |
2,000 |
2,170,782 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-02-28 |
4 |
B |
$2.66 |
$21,280 |
D/D |
8,000 |
1,642,899 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2017-02-28 |
4 |
B |
$2.66 |
$21,280 |
I/I |
8,000 |
2,168,782 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-12-30 |
4 |
B |
$2.13 |
$660 |
D/D |
300 |
1,634,899 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-12-30 |
4 |
B |
$2.13 |
$660 |
I/I |
300 |
2,160,782 |
1.42 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-12-29 |
4 |
B |
$1.97 |
$8,360 |
D/D |
4,000 |
1,634,599 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-12-29 |
4 |
B |
$1.97 |
$8,360 |
I/I |
4,000 |
2,160,482 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-12-28 |
4 |
B |
$1.88 |
$17,860 |
D/D |
9,500 |
1,630,599 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-12-28 |
4 |
B |
$1.88 |
$17,860 |
I/I |
9,500 |
2,156,482 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-12-16 |
4 |
B |
$2.00 |
$10,000 |
D/D |
5,000 |
1,621,099 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-12-16 |
4 |
B |
$2.00 |
$10,000 |
I/I |
5,000 |
2,146,982 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-11-15 |
4 |
B |
$1.87 |
$3,740 |
D/D |
2,000 |
1,616,099 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-11-15 |
4 |
B |
$1.87 |
$3,740 |
I/I |
2,000 |
2,141,982 |
1.42 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-11-03 |
4 |
B |
$2.02 |
$2,020 |
D/D |
1,000 |
1,614,099 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-11-03 |
4 |
B |
$2.02 |
$2,020 |
I/I |
1,000 |
2,139,982 |
1.42 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-10-28 |
4 |
B |
$2.04 |
$2,040 |
D/D |
1,000 |
1,613,099 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-10-28 |
4 |
B |
$2.04 |
$2,040 |
I/I |
1,000 |
2,138,982 |
1.42 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-09-30 |
4 |
B |
$2.09 |
$10,450 |
D/D |
5,000 |
1,612,099 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-09-30 |
4 |
B |
$2.09 |
$10,450 |
I/I |
5,000 |
2,137,982 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-09-29 |
4 |
B |
$2.06 |
$14,420 |
D/D |
7,000 |
1,607,099 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-09-29 |
4 |
B |
$2.06 |
$14,420 |
I/I |
7,000 |
2,132,982 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-09-21 |
4 |
B |
$2.11 |
$211 |
D/D |
100 |
1,600,099 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-09-21 |
4 |
B |
$2.11 |
$211 |
I/I |
100 |
2,125,982 |
1.42 |
- |
|
268 Records found
|
|
Page 6 of 11 |
|
|
0.15 (1.62%) 
